Preeclampsia Laboratory Testing Market by Product Type, Test, and Geography - Forecast and Analysis 2023-2027

Published: Mar 2023

Pages: 162

SKU: IRTNTR75037

Snapshot

The preeclampsia laboratory testing market is estimated to grow at a CAGR of 8% between 2022 and 2027. The size of the market is forecasted to increase by USD 785.73 million. The growth of the market depends on several factors, including market expansion in emerging economies, the increasing incidence of preterm births, and the rising number of gynecology clinics.

This report extensively covers market segmentation by product type (consumables and instruments), test (blood test, urine test, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Preeclampsia Laboratory Testing Market During the Forecast Period?

To learn more about this report, Download Report Sample

Preeclampsia Laboratory Testing Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing incidence of preterm births is notably driving the market growth, although factors such as lack of reimbursement may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Preeclampsia Laboratory Testing Market Driver

The increasing incidence of preterm births is notably driving the preeclampsia laboratory testing market growth.
A preterm birth is defined as birth before 37 weeks of pregnancy. The number of preterm births has increased at a rapid pace, especially in developing economies such as India.
In less developed countries such as Bangladesh, Afghanistan, and Central Africa, the main causes of preterm births are infections, malaria, and high adolescent pregnancy rates.
Preterm births are a major risk factor for jaundice in newborns. According to the Centers for Disease Control and Prevention (CDC), neonatal jaundice occurs in around 80% of premature babies.
Therefore, the rising number of premature infants will increase the adoption of preeclampsia laboratory testing, which will drive the market growth during the forecast period.

Significant Preeclampsia Laboratory Testing Market Trend

The growing need for companion diagnostics is a key trend influencing the preeclampsia laboratory testing market growth.
A companion diagnostic is an in-vitro point-of-care (POC) medical device that provides necessary information for the safe and effective use of a similar drug or biological product.
In Europe, POC devices are regulated under the 1998 European Directive 98/79/EC on in-vitro diagnostic medical devices.
Companion diagnostics are necessary to provide personalized medicines.
Preeclampsia laboratory testing products help in prescribing personalized medication, which will have a positive impact on the market.

Major Preeclampsia Laboratory Testing Market Challenge

Lack of reimbursement may impede the preeclampsia laboratory testing market growth.
Public and private insurers do not reimburse for preeclampsia laboratory testing.
Pregnant women are eligible for Medicaid but can lose coverage at sixty days postpartum, which makes them unable to afford preeclampsia laboratory testing.
Several state and federal agents and healthcare officials have encouraged payers to revise the reimbursement systems of preeclampsia laboratory testing.
However, there is still a lack of reimbursement services with respect to preeclampsia laboratory testing, which will pose a challenge to the growth of the global preeclampsia laboratory testing market during the forecast period.

Key Preeclampsia Laboratory Testing Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Preeclampsia Laboratory Testing Market Customer Landscape

Who are the Major Preeclampsia Laboratory Testing Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers preeclampsia laboratory testing such as i-STAT TOTAL beta-hCG CARTRIDGE.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What are the Fastest-Growing Segments in the Preeclampsia Laboratory Testing Market?

The market share growth by the consumables segment will be significant during the forecast period. Consumables are necessary for the selection and enrichment of preeclampsia laboratory testing procedures. Reagents are chemical substances or mixtures that are used during preeclampsia laboratory procedures. Factors such as the low cost and high usage frequency of consumables are driving the growth of the consumables segment.

Get a glance at the market contribution of various segments Request a PDF Sample

The consumables segment was valued at USD 867.00 million in 2017 and continue to grow until 2021. The consumables segment is likely to grow at a rapid pace during the forecast period. Many suppliers are investing in reagents and consumables, as they generate a high return on investment (ROI). Many government organizations such as the National Institute of Health (NIH) offer grants for the quarterly reimbursements of R&D of consumables. Therefore, the use of reagents and consumables will increase due to the rise in the number of point-of-care testing in hospitals, clinics, and homes and the growth of online purchases.

Which are the Key Regions for the Preeclampsia Laboratory Testing Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The US is the leading country in the market in North America. The growth of the market in this country is attributed to factors such as the rising focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors. In Canada, the increasing awareness about maternal and fetal healthcare through the Canadian Fetal Health Surveillance Program and the Canadian Premature Babies Foundation (CPBF) has led to the rapid adoption of preeclampsia laboratory testing products in maternity clinical settings. In Mexico, increasing government and private hospital budgets, a growing number of hospitals and maternity centers, a high neonatal mortality rate, and the growing demand for high-tech pregnancy screening devices and maternity care facilities are driving the growth of the preeclampsia laboratory testing market in the country.

This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 in 2020 led to industry closures. Due to the medical community's focus on treating COVID-19, the funding for R&D related to preeclampsia laboratory testing products was reduced. This hindered the growth of the regional market. However, in 2021, owing to the initiation of vaccination drives, the regional market started to recover, and it is expected to witness growth during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Product Type Outlook (USD Million, 2017 - 2027)
- Consumables
- Instruments

Test Outlook (USD Million, 2017 - 2027)
- Blood test
- Urine test
- Others

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- ROW
  - Australia
  - Argentina
  - Rest of the world

Parent Market Analysis

The reports categorize the global preeclampsia laboratory testing market as a part of the life sciences tools & services, which covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Preeclampsia Laboratory Testing Market Scope
Report Coverage	Details
Page number	162
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 8%
Market growth 2023-2027	USD 785.73 million
Market structure	Fragmented
YoY growth 2022-2023(%)	7.45
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Germany, UK, China, and India
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Preeclampsia Laboratory Testing Market Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the preeclampsia laboratory testing market between 2023 and 2027
Precise estimation of the size of the preeclampsia laboratory testing market size and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of preeclampsia laboratory testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Test
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global preeclampsia laboratory testing market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global preeclampsia laboratory testing market 2017 - 2021 ($ million)

4.2 Product Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Type Segment 2017 - 2021 ($ million)

4.3 Test Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Test Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product Type

6.1 Market segments
- Exhibit 30: Chart on Product Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product Type - Market share 2022-2027 (%)

6.2 Comparison by Product Type
- Exhibit 32: Chart on Comparison by Product Type
- Exhibit 33: Data Table on Comparison by Product Type

6.3 Consumables - Market size and forecast 2022-2027
- Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

6.4 Instruments - Market size and forecast 2022-2027
- Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Product Type
- Exhibit 42: Market opportunity by Product Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Product Type ($ million)

7 Market Segmentation by Test

7.1 Market segments
- Exhibit 44: Chart on Test - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Test - Market share 2022-2027 (%)

7.2 Comparison by Test
- Exhibit 46: Chart on Comparison by Test
- Exhibit 47: Data Table on Comparison by Test

7.3 Blood test - Market size and forecast 2022-2027
- Exhibit 48: Chart on Blood test - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Blood test - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Blood test - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Blood test - Year-over-year growth 2022-2027 (%)

7.4 Urine test - Market size and forecast 2022-2027
- Exhibit 52: Chart on Urine test - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Urine test - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Urine test - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Urine test - Year-over-year growth 2022-2027 (%)

7.5 Others - Market size and forecast 2022-2027
- Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by Test
- Exhibit 60: Market opportunity by Test ($ million)
- Exhibit 61: Data Table on Market opportunity by Test ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 China - Market size and forecast 2022-2027
- Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

9.10 UK - Market size and forecast 2022-2027
- Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.11 India - Market size and forecast 2022-2027
- Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 111: Abbott Laboratories - Overview
- Exhibit 112: Abbott Laboratories - Business segments
- Exhibit 113: Abbott Laboratories - Key news
- Exhibit 114: Abbott Laboratories - Key offerings
- Exhibit 115: Abbott Laboratories - Segment focus

12.4 ACON Laboratories Inc.
- Exhibit 116: ACON Laboratories Inc. - Overview
- Exhibit 117: ACON Laboratories Inc. - Product / Service
- Exhibit 118: ACON Laboratories Inc. - Key offerings

12.5 Bio Rad Laboratories Inc.
- Exhibit 119: Bio Rad Laboratories Inc. - Overview
- Exhibit 120: Bio Rad Laboratories Inc. - Business segments
- Exhibit 121: Bio Rad Laboratories Inc. - Key news
- Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 123: Bio Rad Laboratories Inc. - Segment focus

12.6 BioCheck Inc.
- Exhibit 124: BioCheck Inc. - Overview
- Exhibit 125: BioCheck Inc. - Product / Service
- Exhibit 126: BioCheck Inc. - Key offerings

12.7 bioMerieux SA
- Exhibit 127: bioMerieux SA - Overview
- Exhibit 128: bioMerieux SA - Product / Service
- Exhibit 129: bioMerieux SA - Key offerings

12.8 Biora Therapeutics Inc.
- Exhibit 130: Biora Therapeutics Inc. - Overview
- Exhibit 131: Biora Therapeutics Inc. - Product / Service
- Exhibit 132: Biora Therapeutics Inc. - Key offerings

12.9 Cardinal Health Inc.
- Exhibit 133: Cardinal Health Inc. - Overview
- Exhibit 134: Cardinal Health Inc. - Business segments
- Exhibit 135: Cardinal Health Inc. - Key news
- Exhibit 136: Cardinal Health Inc. - Key offerings
- Exhibit 137: Cardinal Health Inc. - Segment focus

12.10 Diabetomics Inc.
- Exhibit 138: Diabetomics Inc. - Overview
- Exhibit 139: Diabetomics Inc. - Product / Service
- Exhibit 140: Diabetomics Inc. - Key offerings

12.11 F. Hoffmann La Roche Ltd.
- Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus

12.12 MedGyn Products Inc.
- Exhibit 146: MedGyn Products Inc. - Overview
- Exhibit 147: MedGyn Products Inc. - Product / Service
- Exhibit 148: MedGyn Products Inc. - Key offerings

12.13 Metabolomic Diagnostics
- Exhibit 149: Metabolomic Diagnostics - Overview
- Exhibit 150: Metabolomic Diagnostics - Product / Service
- Exhibit 151: Metabolomic Diagnostics - Key offerings

12.14 Perkin Elmer Inc.
- Exhibit 152: Perkin Elmer Inc. - Overview
- Exhibit 153: Perkin Elmer Inc. - Business segments
- Exhibit 154: Perkin Elmer Inc. - Key news
- Exhibit 155: Perkin Elmer Inc. - Key offerings
- Exhibit 156: Perkin Elmer Inc. - Segment focus

12.15 Sera Prognostics Inc.
- Exhibit 157: Sera Prognostics Inc. - Overview
- Exhibit 158: Sera Prognostics Inc. - Product / Service
- Exhibit 159: Sera Prognostics Inc. - Key offerings

12.16 Siemens AG
- Exhibit 160: Siemens AG - Overview
- Exhibit 161: Siemens AG - Business segments
- Exhibit 162: Siemens AG - Key news
- Exhibit 163: Siemens AG - Key offerings
- Exhibit 164: Siemens AG - Segment focus

12.17 Thermo Fisher Scientific Inc.
- Exhibit 165: Thermo Fisher Scientific Inc. - Overview
- Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 167: Thermo Fisher Scientific Inc. - Key news
- Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 170: Inclusions checklist
- Exhibit 171: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 172: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 173: Research methodology
- Exhibit 174: Validation techniques employed for market sizing
- Exhibit 175: Information sources

13.5 List of abbreviations
- Exhibit 176: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

preeclampsia laboratory testing market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis